Moderna Inc
MRNA
NASDAQ
Biotechnology
$63.32
USD
-0.33 (-0.52%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $25.19B
Volume 4.7M
Revenue
$2.23B
TTM
-27.6%
YoY
Gross Margin
23%
TTM
-55.5%
YoY
Net Income
$-3.15B
TTM
-8.5%
YoY
Operating Cash Flow
$-1.07B
TTM
+60.2%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 142.0 | 1,016.0 | 678.0 | 389.0 | 145.0 |
YoY Growth | -41.1% | -45.4% | -29.8% | +260.2% | +2.1% |
Cost of Revenue | 119.0 | 207.0 | 452.0 | 955.0 | 93.0 |
Gross Profit | 23.0 | 809.0 | 226.0 | -566.0 | 52.0 |
Selling, General & Administrative | 230.0 | 268.0 | 308.0 | 173.0 | 216.0 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 930.0 | 1,069.0 | 1,083.0 | 822.0 | 867.0 |
Operating Income | -907.0 | -260.0 | -857.0 | -1,388.0 | -815.0 |
EBITDA | -850.0 | -208.0 | -790.0 | -1,329.0 | -752.0 |
Other Income / Expense | 9.0 | 0.0 | -12.0 | -18.0 | -2.0 |
Total Other Income / Expense | 89.0 | 73.0 | 58.0 | 54.0 | 48.0 |
Income Before Income Taxes | -818.0 | -187.0 | -799.0 | -1,334.0 | -767.0 |
Income Taxes | 7.0 | 13.0 | 27.0 | 9.0 | 15.0 |
Net Income | -825.0 | -200.0 | -826.0 | -1,343.0 | -782.0 |
Consolidated Net Income / Loss | -825.0 | -200.0 | -826.0 | -1,343.0 | -782.0 |
Net Income Attributable to Common Shareholders | -825.0 | -200.0 | -826.0 | -1,343.0 | -782.0 |
Basic EPS | -$2.13 | -$0.51 | -$2.11 | -$3.40 | -$1.97 |
Diluted EPS | -$2.13 | -$0.51 | -$2.11 | -$3.40 | -$1.97 |
Basic Shares Outstanding | 388.0M | 390.0M | 392.0M | 395.0M | 398.0M |
Diluted Shares Outstanding | 388.0M | 390.0M | 392.0M | 395.0M | 398.0M |